Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01808898
Other study ID # 12/BWH/NO75
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date February 2013
Est. completion date February 2015

Study information

Verified date May 2015
Source Birmingham Women's and Children's NHS Foundation Trust
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The usual intervention to control the pain during an outpatient endometrial ablation has been to use local anaesthesia (LA) injection just in the neck of the womb (cervix). However, this alone may not be sufficient to control the pain completely. Therefore, we want to find out whether an injection of LA given deep into the muscle of the womb (myometrium), in addition to that in the cervix, has a better effect on controlling the pain during the procedure.

All women attending gynaecology outpatient clinics, who have consented for an outpatient hysteroscopic procedure, will be invited to take part in the study. The study will be carried out in the outpatient hysteroscopy clinic at Birmingham Women's Hospital.

As part of standard pain control method during an outpatient endometrial ablation, all women will receive an injection of LA in the cervix of the uterus to 'freeze it'. During hysteroscopy a randomly selected treatment group will receive an injection into deep muscle containing only normal saline (control group) whereas the experiment group will receive fast / long acting local anaesthesia (cornual block).

Women will be asked to rate the degree of pain by placing a mark on an ungraduated 10 cm horizontal line. These scales will be given before the procedure, during LA injection, immediately after, one hour and at the time of discharge from hospital.

The results will help future patients undergoing a similar procedure to have much better pain relief and allow many more to have the procedure without the side effects of a general anaesthetic and its risks. In addition to having less pain, it may reduce the number of painkillers needed as well as any stay in hospital. In future this may also allow a greater variety of procedures to be done in an outpatient setting.


Description:

Outpatient local anaesthesic (LA) hysteroscopic intrauterine therapeutic interventions such as endometrial ablation have gained wider acceptance in the last decade. However, pain experienced during these procedures can be a disincentive and is the commonest reason for the use of escalating levels of analgesia post procedure, which results in prolongation of hospital stay and recovery. Various methods of LA have been studied including intrauterine topical lignocaine or cervical block using topical lignocaine, paracervical block or intracervical block. However, a single site block individually may not be sufficient to control the pain completely due to inability of the one site block to affect the sensitivity of the whole uterus, as the uterine fundus is effectively still unanaesthetised. This may be due to the uterus receiving complex innervations from different nerve routes such as the uterovaginal plexus, the Frankenhauser nerve plexuses, parasympathetic ganglia and the thoracic nerve.

Therefore, it seems logical to use a direct cervical block to block the sensation through uterovaginal plexus and use an additional deep myometrial block adjacent to each cornua to directly block the thoracic nerve supply. To date, only one small observational study has looked at the effect of such a combined block in relieving pain during outpatient hysteroscopic procedures. Therefore, we propose to undertake a double blind randomised controlled trial to address this question by comparing effectiveness of a standard direct cervical block and intrauterine cornual block (ICOB) versus a direct cervical block and a normal saline intrauterine cornual injection (control).


Recruitment information / eligibility

Status Completed
Enrollment 93
Est. completion date February 2015
Est. primary completion date February 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria:

- All women between the ages of 18 - 50 years presenting to the gynaecology outpatient clinic scheduled for an outpatient hysteroscopic intrauterine therapeutic intervention such as endometrial ablation.

Exclusion Criteria:

- Women with contraindications to hysteroscopic procedures such as atypical endometrial hyperplasia or endometrial cancer, undiagnosed abnormal vaginal bleeding, current lower pelvic infection or uterine abnormalities

- Women who are allergic to local anaesthesia

- Not technically possible to perform a hysteroscopy e.g. women with distorted uterine cavity due to large fibroids

- Women considered vulnerable (e.g. current mental illness, emotionally labile, or learning difficulties)

- Women who decline to be randomised and request the additional anaesthetic or decline it will form a separate group to be studied and will be administered the VAS similar to the trial group. This group will be analysed separately to determine whether they are significantly different to those patients who consent to being part of the trial.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Local Anaesthetic
On the day of the procedure and before the patients are treated, a designated clinician will draw up the local anaesthetic (2mls consisting of 1ml of 3% mepivacaine (short / medium acting) and 1ml of 0.5% bupivacaine (long acting)

Locations

Country Name City State
United Kingdom Birmingham Women's Hospital Birmingham

Sponsors (2)

Lead Sponsor Collaborator
Birmingham Women's and Children's NHS Foundation Trust University of Birmingham

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Visual Analogue scale evaluating pain To determine the effectiveness of intrauterine cornual block by evaluating pain directly attributable to outpatient hysteroscopic endometrial ablation assessed by using an ungraduated 10 cm visual analogue scale (VAS) administered immediately after the procedure prior to shifting patient to the recovery unit. administered immediately after the procedure
Secondary Visual Analogue scale evaluating pain To determine the effectiveness of intrauterine cornual block by evaluating pain using VAS at 1 hour after the procedure and prior to discharge from the hospital.
To assess the total requirements for rescue analgesia in the first 24-hour post-operative period between the two groups.
1 hour after procedure and at discharge from hospital
See also
  Status Clinical Trial Phase
Recruiting NCT05001282 - A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRĪ±) Phase 1/Phase 2
Recruiting NCT04145518 - Mechanistic Characterization of Uterine Pain Phase 4
Recruiting NCT03756480 - Cancer Driving Mutations in Endometriosis Lesions and Development of Progesterone Resistance
Recruiting NCT03748238 - Endometrial Injury In Recurrent Implantation Failure N/A
Completed NCT05283642 - D-chiro-inositol and Endometrial Thickness N/A
Completed NCT03519763 - Intrauterine Microbiota During IVF in Patients Affected With Isthmocele.
Completed NCT03207074 - Can the iKnife Distinguish Between Normal and Malignant Endometrial Tissue? N/A
Recruiting NCT03289468 - Study of Diagnosis of Color Power Doppler Combined Minimally Invasive Sampling for Endometrial Diseases
Completed NCT03755973 - Effect of Different Ovarian Stimulation Protocols on Endometrial Receptivity Phase 4
Withdrawn NCT04184323 - SIRT-1 Antagonism for Endometrial Receptivity Phase 2
Completed NCT06316180 - The Use of Drospirenone/Estetrol in Random Start Rapid Endometrial Preparation Phase 4
Completed NCT06316206 - The Use of Ethinylestradiol/Dienogest in Random Start Rapid Endometrial Preparation Phase 4
Completed NCT06316219 - The Use of Nomegestrol Acetate/Estradiol in Random Start Rapid Endometrial Preparation Phase 4
Completed NCT06324851 - The Use of Drospirenone/Estetrol, Nomegestrol Acetate/Estradiol and Ethinylestradiol/Dienogest in Random Start Rapid Endometrial Preparation Phase 4
Recruiting NCT06264921 - A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors Phase 1
Completed NCT03060603 - Proliferative Effects of Erythropoietin on Human Endometrium N/A
Completed NCT05472740 - Transcutaneous Electrical Nerve Stimulation During Outpatient Endometrial Biopsy N/A
Completed NCT02716636 - Fast Versus Slow Tenaculum Placement N/A